Search

Your search keyword '"NPS Pharmaceuticals Inc."' showing total 1,682 results
Start Over Descriptor "NPS Pharmaceuticals Inc."
1,682 results on '"NPS Pharmaceuticals Inc."'

201. NPS Pharmaceuticals Shares Down 10.9% Since SmarTrend's Sell Call (NPSP)

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

Mar 25, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified a Downtrend for NPS Pharmaceuticals (NASDAQ:NPSP) on March 6th, 2014 at $33.22. In approximately 3 weeks, NPS Pharmaceuticals has returned [...]

Published
2014

202. McKesson Board of Directors Elects N. Anthony Coles as New Independent Director

Subjects
McKesson Corp., NPS Pharmaceuticals Inc., Corporate directors, Biological products, Boards of directors, Pharmaceutical industry, Business, Business, international
Abstract

SAN FRANCISCO -- As a next step in a series of corporate governance modifications, McKesson Corporation (NYSE: MCK) today announced that its Board of Directors has elected N. Anthony Coles, [...]

Published
2014

203. NPS Pharmaceuticals Has Returned 30.2% Since SmarTrend Recommendation (NPSP)

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

Mar 05, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on December 19th, 2013 at $27.04. In approximately 3 months, NPS Pharmaceuticals has returned [...]

Published
2014

204. 8-K: MCKESSON CORP

Subjects
McKesson Corp., NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, general
Abstract

(EDGAR Online via COMTEX) -- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF [...]

Published
2014

205. NPS Pharmaceuticals to Present at Barclays Global Healthcare Conference

Subjects
NPS Pharmaceuticals Inc., Health care industry, Pharmaceutical industry, Health care industry, Business, Business, international
Abstract

BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the Barclays Global Healthcare Conference in Miami, Florida on Tuesday, March 11, 2014 at 9:00 a.m. ET. The presentation will [...]

Published
2014

206. NPS Pharmaceuticals Has Returned 43.2% Since SmarTrend Recommendation (NPSP)

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

Feb 26, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on December 19th, 2013 at $27.04. In approximately 2 months, NPS Pharmaceuticals has returned [...]

Published
2014

207. Potential NPS Pharmaceuticals (NPSP) Trade Targets 8.31% Return

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Personal finance
Abstract

Feb 25, 2014 (Marketintelligencecenter.com via COMTEX) -- The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center are highlighting two trades on NPS Pharmaceuticals Inc (NPSP) today after it [...]

Published
2014

208. 37.0% Return Seen to Date on SmarTrend NPS Pharmaceuticals Call (NPSP)

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

Feb 19, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on December 19th, 2013 at $27.04. In approximately 2 months, NPS Pharmaceuticals has returned [...]

Published
2014

209. Downgrade Alert for NPS Pharmaceuticals (NPSP)

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

Feb 19, 2014 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- NPS Pharmaceuticals (NASDAQ:NPSP) was downgraded from Buy to Hold at Jefferies today. The stock closed yesterday at $37.95 on volume of 2.4 [...]

Published
2014

211. 10-K: NPS PHARMACEUTICALS INC

Subjects
United States. Food and Drug Administration, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, general
Abstract

(EDGAR Online via COMTEX) -- ITEM 7. Management's Discussion and Analysis of Financial Condition and Results of Operations. SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS The following discussion should be read [...]

Published
2014

212. Trade-Ideas: NPS Pharmaceuticals (NPSP) Is Today's Post-Market Leader Stock

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

Byline: Scott Olson To view this article on the web, click here: http://www.thestreet.com/story/12318879/1/trade-ideas-nps-pharmaceuticals-npsp-is-todays-post-market-leader-stock.html Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of [...]

Published
2014

213. Potential NPS Pharmaceuticals (NPSP) Trade Targets 9.71% Return

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Personal finance
Abstract

Feb 03, 2014 (Marketintelligencecenter.com via COMTEX) -- For a hedged play on NPS Pharmaceuticals Inc (NPSP) MarketIntelligenceCenter.comaEUR(TM)s algorithms selected the May. '14 $33.00 covered call for a net debit in [...]

Published
2014

214. Medical Director. (Medical Doctors)

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Health care industry, Pharmaceuticals and cosmetics industries
Published
2003

216. NPS Pharmaceuticals Up 35.0% Since SmarTrend Uptrend Call (NPSP)

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

Jan 28, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on December 19th, 2013 at $27.04. In approximately 1 month, NPS Pharmaceuticals has returned [...]

Published
2014

217. NPS Pharmaceuticals Shares Up 36.4% Since SmarTrend's Buy Recommendation (NPSP)

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

Jan 21, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on December 19th, 2013 at $27.04. In approximately 1 month, NPS Pharmaceuticals has returned [...]

Published
2014

218. NPS Pharmaceuticals Inc Stock Upgraded (NPSP)

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

Byline: Kevin Baker To view this article on the web, click here: http://www.thestreet.com/story/12250650/1/nps-pharmaceuticals-inc-stock-upgraded-npsp.html Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of [...]

Published
2014

219. Commit To Buy NPS Pharmaceuticals At $23, Earn 13.5% Using Options

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

Byline: StockOptionsChannel.com To view this article on the web, click here: http://www.thestreet.com/story/12243173/1/commit-to-buy-nps-pharmaceuticals-at-23-earn-135-using-options.html Investors considering a purchase of NPS Pharmaceuticals Inc. (NPSP) shares, but tentative about paying the going market price [...]

Published
2014

220. NPS Pharmaceuticals Inc's BLA for Natpara to be reviewed by the US FDA for treating hypoparathyroidism

Subjects
United States. Food and Drug Administration, NPS Pharmaceuticals Inc., Parathyroid hormone, Pharmaceutical industry, Hypoparathyroidism -- Care and treatment, General interest, News, opinion and commentary
Abstract

Jan 08, 2014 (M2 EQUITYBITES via COMTEX) -- Biopharmaceutical company NPS Pharmaceuticals Inc (NasdaqGS:NPSP) said on Tuesday that its Biologics License Application (BLA) for Natpara for the treatment of hypoparathyroidism [...]

Published
2014

221. NPS Pharmaceuticals Announces FDA Acceptance of Biologics License Application for Natpara[R] for the Treatment of Hypoparathyroidism

Subjects
United States. Food and Drug Administration, NPS Pharmaceuticals Inc., Parathyroid hormone, Drugs -- Prescribing, Pharmaceutical industry, Hypoparathyroidism, Business, Business, international
Abstract

Prescription Drug User Fee Act (PDUFA) Goal Date of October 24, 2014 BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the [...]

Published
2014

222. NPS Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

Subjects
JPMorgan Chase & Co., NPS Pharmaceuticals Inc., Banking industry, Health care industry, Pharmaceutical industry, Health care industry, Banking industry, Business, Business, international
Abstract

BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco Tuesday, January 14, 2014 at 3:30 p.m. PT. The presentation [...]

Published
2014

223. NPS Pharmaceuticals Inc wins orphan drug designation for Natpara for the treatment of hypoparathyroidism in Europe

Subjects
United States. Food and Drug Administration, NPS Pharmaceuticals Inc., Parathyroid hormone, Orphan drugs, Pharmaceutical industry, Hypoparathyroidism -- Drug therapy, General interest, News, opinion and commentary
Abstract

Jan 06, 2014 (M2 EQUITYBITES via COMTEX) -- Biopharmaceutical company NPS Pharmaceuticals Inc (NasdaqGS:NPSP) reported on Friday the receipt of the European Commission's orphan drug designation for Natpara (recombinant human [...]

Published
2014

224. Uptrend Call Working As NPS Pharmaceuticals Stock Rises 19.8% (NPSP)

Subjects
NPS Pharmaceuticals Inc., Stocks -- Prices and rates, Pharmaceutical industry, Business
Abstract

Jan 03, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on December 19th, 2013 at $27.04. In approximately 2 weeks, NPS Pharmaceuticals has returned [...]

Published
2014

225. Sector Update: Healthcare

Subjects
NPS Pharmaceuticals Inc., Health care industry, Pharmaceutical industry, Health care industry, Business
Abstract

Boston, Jan 03, 2014 (MidnightTrader via COMTEX) -- Healthcare shares are fairly flat in pre-market trade. NPS Pharmaceuticals, Inc. (NPSP) announced that the European Commission has granted orphan drug designation [...]

Published
2014

226. NPS Pharmaceuticals' Natpara Receives Orphan Drug Designation in Europe; Shares Up 1% in Pre-Market

Subjects
United States. Food and Drug Administration, NPS Pharmaceuticals Inc., Parathyroid hormone, Orphan drugs, Pharmaceutical industry, Business
Abstract

Boston, Jan 03, 2014 (MidnightTrader via COMTEX) -- NPS Pharmaceuticals, Inc. (NPSP) said Friday that the European Commission has granted orphan drug designation to Natpara (recombinant human parathyroid hormone (rhPTH[1-84]) [...]

Published
2014

227. NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara[R] in Europe

Subjects
NPS Pharmaceuticals Inc., Parathyroid hormone, Orphan drugs, Pharmaceutical industry, Business, Business, international, European Union
Abstract

BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European [...]

Published
2014

228. NPS Pharmaceuticals Begins Registration for Short Bowel Syndrome Product Study

Subjects
NPS Pharmaceuticals Inc., Medical research, Medicine, Experimental, Malabsorption syndromes, Pharmaceutical industry, Business
Abstract

Boston, Jan 02, 2014 (MidnightTrader via COMTEX) -- NPS Pharmaceuticals, Inc. (NPSP) has begun a global registration study of teduglutide in pediatric patients with Short Bowel Syndrome (SBS) who are [...]

Published
2014

229. NPS Pharmaceuticals Initiates Global Registration Study of Teduglutide in Pediatric Patients with Short Bowel Syndrome

Subjects
NPS Pharmaceuticals Inc., Medical research, Medicine, Experimental, Children -- Health aspects, Malabsorption syndromes -- Care and treatment, Pharmaceutical industry, Business, Business, international
Abstract

-- 12-Week Study Will Assess Teduglutide in Pediatric Patients Dependent on Parenteral Support -- BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies [...]

Published
2014

230. Salt Lake City-based biopharmaceutical firm secures financing for drug launch

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, General interest, Business, regional
Abstract

Byline: Bob Mims Dec. 24--NPS Pharmaceuticals Inc. has completed a private placement of $175 million in notes, saying the financing will help launch its Preos osteoporosis compound and other drugs. [...]

Published
2004

231. Salt Lake City-based drug maker places $175 million in private notes

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, General interest, Business, regional
Abstract

Byline: Bob Mims Dec. 23--NPS Pharmaceuticals Inc. has completed a private placement of $175 million in notes, saying the financing will help launch its Preos osteoporosis compound and other drugs. [...]

Published
2004

232. BIG DEALS.

Author

Marcus, David

Subjects
*MERGERS & acquisitions
Abstract

Presents information on several merger deals in the U.S. as of June 2003. Devon Energy Corp. and Ocean Energy, Inc.; Enzon Pharmaceuticals, Inc. and NPS Pharmaceuticals, Inc.; USA Interactive and Expedia, Inc.

Published
2003

233. Nps Pharmaceuticals Inc. Files SEC Form 15-12G, Securities Registration Termination [Section 12(G)] (Mar. 5, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

234. Nps Pharmaceuticals Inc. Files SEC Form POSASR, Post-effective Amendment To An Automatic Shelf Registration Statement (Feb. 23, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

235. Nps Pharmaceuticals Inc. Files SEC Form POS AM, Post-effective Amendments For Registration Statement (Feb. 23, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

236. Nps Pharmaceuticals Inc. Files SEC Form SC TO-T, Tender Offer Statement By Third Party [Amend] (Feb. 23, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

237. Nps Pharmaceuticals Inc. Files SEC Form S-8 POS, Securities To Be Offered To Employees in Employee Benefit Plans, Post-effective Amendments (Feb. 23, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Employee benefits, Employee benefits, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

238. Nps Pharmaceuticals Inc. Files SEC Form SC 14D9, Solicitation, Recommendation Statements [Amend] (Feb. 23, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

239. Nps Pharmaceuticals Inc. Files SEC Form 25-NSE, Notification Filed By National Security Exchange To Report The Removal From Listing And Registration of Matured, Redeemed Or Retired Securities (Feb. 23, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

240. Nps Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Feb. 20, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

241. Nps Pharmaceuticals Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-K Item 405] [Amend] (Feb. 23, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

242. Nps Pharmaceuticals Inc. Files SEC Form SC TO-T, Tender Offer Statement By Third Party [Amend] (Feb. 17, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

243. Nps Pharmaceuticals Inc. Files SEC Form SC 13G, Statement of Acquisition of Beneficial Ownership By Individuals [Amend] (Feb. 12, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

244. Nps Pharmaceuticals Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-K Item 405] (Feb. 18, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

245. Nps Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Feb. 12, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

246. Deal snapshot: SHIRE CLOSES USD 5.2BN NPS PHARMA ACQUISITION

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, general
Abstract

MANews-(C)2009-2015 Irish pharmaceutical company Shire plc (LSE: SHP) (NASDAQ: SHPG) has closed tender offer for all of the outstanding shares of US-based NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) and the subsequent [...]

Published
2015

247. Shire Closes USD 5.2bn NPS Pharma Acquisition

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, general
Abstract

MANews-(C)2009-2015 23 February 2015 - Irish pharmaceutical company Shire plc (LSE: SHP) (NASDAQ: SHPG) has closed tender offer for all of the outstanding shares of US-based NPS Pharmaceuticals, Inc. (NASDAQ: [...]

Published
2015

248. Shire Closes USD 5.2bn NPS Pharma Acquisition

Subjects
NPS Pharmaceuticals Inc., Pharmaceutical industry, Business
Abstract

M2 EQUITYBITES-February 23, 2015-Shire Closes USD 5.2bn NPS Pharma Acquisition (C)2015 M2 COMMUNICATIONS http://www.m2.com 23 February 2015 - Irish pharmaceutical company Shire plc (LSE: SHP) (NASDAQ: SHPG) has closed tender [...]

Published
2015

249. Nps Pharmaceuticals Inc. Files SEC Form SC TO-T, Tender Offer Statement By Third Party [Amend] (Feb. 9, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

250. Nps Pharmaceuticals Inc. Files SEC Form SC 14D9, Solicitation, Recommendation Statements [Amend] (Feb. 6, 2015)

Subjects
United States. Securities and Exchange Commission, NPS Pharmaceuticals Inc., Pharmaceutical industry, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing [...]

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results